Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule. The company was incorporated in 2005 and is based in Caesarea, Israel.
Stock data | 2024 | Change |
---|---|---|
Price | $3.72 | N/A |
Market Cap | $110.62M | N/A |
Shares Outstanding | 29.73M | N/A |
Employees | 0 | N/A |